HHSN2610006 title: modulation of mirna expression in blood or other biological fluids compared with tissue levels in mice exposed to cigarette smoke and/or with nsaids. Period of performance:…
Ended Awarded Last action
- Contract number
- HHSN26100006
- Awardee
-
The Institute For Cancer Research UEI FF1XVJMDYVR1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $567,649
Award facts
- Opportunity
-
- N01CN2500278 Solicitation number
- Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Feb 27, 2012
- Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Dec 15, 2011
- Contract value 100% obligated
- $567,649.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19111, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$7,511 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $575,160 |
Description
HHSN2610006 title: modulation of mirna expression in blood or other biological fluids compared with tissue levels in mice exposed to cigarette smoke and/or with nsaids. Period of performance: 09/18/2014-09/17/2016
Quick answers
Who was awarded contract HHSN26100006?
HHSN26100006 was awarded to The Institute For Cancer Research by National Cancer Institute (National Institutes of Health) on September 18, 2014.
How much is contract HHSN26100006 worth?
The government has obligated $567,649 on HHSN26100006.
Is contract HHSN26100006 an order under another contract?
Yes. HHSN26100006 is a delivery order under HHSN261201200015I, an indefinite delivery contract, on Preclinical Efficacy and Intermediate Endpoint Biomarkers.
Was contract HHSN26100006 competed?
The extent of competition for HHSN26100006 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award